The Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University.
The Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, China.
J Hypertens. 2024 Jun 1;42(6):1048-1056. doi: 10.1097/HJH.0000000000003693. Epub 2024 Feb 21.
The correlation between systolic blood pressure (SBP) and mortality in hypertensive patients with different phenotypes of heart failure (HF) has not been adequately studied, and optimal blood pressure control targets remain controversial. To explore the link between SBP and prognosis in all or three ejection fraction (EF) phenotypes of HF patients with hypertension.
We analyzed 1279 HF patients complicated by hypertension in a retrospective cohort. The SBP <130 mmHg group included 383 patients, and the SBP ≥130 mmHg group included 896 patients. The major end point was all-cause mortality.
Of the 1279 study patients, with a median age of 66.0 ± 12.0 years, 45.3% were female. The proportions of the three subtypes of heart failure complicated with hypertension (HFrEF, HEmrEF, and HFpEF) were 26.8%, 29.3%, and 43.9%, respectively. During the 1-year follow-up, 223 patients experienced all-cause death, and 133 experienced cardiovascular death. Restricted cubic splines showed that the risk of all-cause and cardiovascular death increased gradually as the SBP level decreased in patients with HFrEF and HFmrEF. Furthermore, the multivariate Cox proportional hazards model revealed that SBP <130 mmHg was also associated with an increased risk of all-cause death [hazard ratio (HR) 2.53, 95% confidence interval (CI) 1.23-5.20, P = 0.011] and cardiovascular death (HR 1.91, 95% CI 1.01-3.63, P = 0.047) in HFrEF patients. A trend toward increased risk was observed among HFmrEF patients, but it was not statistically significant. This trend was not observed in HFpEF patients.
In HFrEF patients, SBP <130 mmHg was associated with an increased risk of all-cause and cardiovascular mortality. A trend toward increased risk was observed among HFmrEF patients, but not among HFpEF patients.
不同心力衰竭(HF)表型的高血压患者的收缩压(SBP)与死亡率之间的相关性尚未得到充分研究,血压控制的最佳目标仍存在争议。探讨所有或三种射血分数(EF)HF 合并高血压患者中 SBP 与预后之间的关系。
我们对回顾性队列中的 1279 例 HF 合并高血压患者进行了分析。SBP<130mmHg 组包括 383 例患者,SBP≥130mmHg 组包括 896 例患者。主要终点是全因死亡率。
1279 例研究患者的中位年龄为 66.0±12.0 岁,45.3%为女性。高血压合并三种心力衰竭亚型(HFrEF、HFmrEF 和 HFpEF)的比例分别为 26.8%、29.3%和 43.9%。在 1 年随访期间,223 例患者发生全因死亡,133 例患者发生心血管死亡。受限立方样条显示,在 HFrEF 和 HFmrEF 患者中,随着 SBP 水平降低,全因和心血管死亡的风险逐渐增加。此外,多变量 Cox 比例风险模型显示,SBP<130mmHg 也与全因死亡风险增加相关[风险比(HR)2.53,95%置信区间(CI)1.23-5.20,P=0.011]和心血管死亡(HR 1.91,95%CI 1.01-3.63,P=0.047)在 HFrEF 患者中。HFmrEF 患者中也观察到风险增加的趋势,但无统计学意义。在 HFpEF 患者中未观察到这种趋势。
在 HFrEF 患者中,SBP<130mmHg 与全因和心血管死亡率增加相关。HFmrEF 患者中也观察到风险增加的趋势,但 HFpEF 患者中未见这种趋势。